Islets co-engineered with thrombomodulin and CD47 achieve sustained survival in allogeneic recipients without chronic immunosuppression
Shadab Kazmi(Cancer Research Center), Haval Shirwan(Cancer Research Center)
Cited by 0
Related Papers
Targeting Interleukin-10 Restores Graft Microvascular Supply and Airway Epithelium in Rejecting Allografts
|International Journal of Molecular Sciences|2022|11